Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Breast Cancer
  • Astrocytoma
  • Bladder Cancer
  • Lung Cancer
  • Thymic Carcinoma
  • Brain Cancer
  • Sarcoma
  • Brain Metastases
  • Cervical Cancer
  • Liver Cancer
  • Melanoma
  • Urinary Tract Cancer
  • Cholangiocarcinoma
  • Pancreatic Cancer
  • Kidney Cancer
  • Tongue Cancer
  • Colorectal Cancer
  • Esophagus Cancer
  • Gastric Cancer
  • Prostate Cancer
  • Head and Neck Cancer
  • Ovarian Cancer
  • Pleural Mesothelioma
Type
Interventional
Phase
Phase 1
Design
Allocation: N/AIntervention Model: Sequential AssignmentIntervention Model Description: The dose escalation scheme for this trial employs an mTPI-2 design.Masking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT04430842
Collaborators
Novotech (Australia) Pty Limited
Investigators
Not Provided